TAMs induce IL-6 secretion, which exerts a synergistic effect along with ALKBH5 to activate p-STAT3 signaling in NSCLC cells, thus maintaining an immunosuppressive microenvironment that drives tumorigenesis. The gene discussed is STAT3; the disease is non-small cell lung carcinoma.